← Back to all trials
Not Yet Recruiting
NCT07857317
Non-Contrast Versus Contrast-Enhanced MRI in Colorectal Liver Metastases
Conditions: Liver Metastases, Liver Neoplasms
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 40
Sponsor: Assiut University
Summary
This prospective study aims to compare the diagnostic performance of a non-contrast abbreviated MRI protocol with a contrast-enhanced MRI protocol for the detection and follow-up assessment of colorectal liver metastases.
Eligibility Criteria
Inclusion Criteria:
* \- Histologically confirmed colorectal adenocarcinoma
* One or more hepatic focal lesions known or suspected to represent colorectal liver metastases
* Adequate image quality allowing reliable assessment of hepatic lesions
* Patients scheduled to receive chemotherapy allowing assessment of treatment response
* Patients referred for initial staging, restaging, or evaluation of treatment response
* Written informed consent
Exclusion Criteria:
* \- Contraindications to gadolinium-based contrast administration
* Incomplete MRI examinations
* Inadequate image quality preventing reliable assessment
* Contraindications to MRI examination
Source: ClinicalTrials.gov (NCT07857317). StuddyBuddy aggregates publicly available trial information.